Čes-slov Pediat 2023, 78(3):141-154 | DOI: 10.55095/CSPediatrie2023/019
Inherited disorders of carbohydrate metabolismKapitoly k atestaci z pediatrie
- Klinika pediatrie a dědičných poruch metabolismu 1. lékařské fakulty Univerzity Karlovy a Všeobecné fakultní nemocnice v Praze
Introduction: Inherited metabolic disorders (IMD) of carbohydrates represent a heterogeneous group of >250 different diseases caused by impaired synthesis, transport or degradation of galactose, fructose, glucose, disaccharides, glycogen, glycosaminoglycans and glycoproteins/glycolipids. Individual IMD of carbohydrates
are rare, but the overall incidence in the population is >1:5 000. Their diagnosis, except galactosemia in some countries is not part of laboratory neonatal screening of IMD and depends on clinical suspicion, biochemical and haematological analyses, and indication of selective metabolic screening.
Material and methods: We summarize our experiences with the clinical, diagnostic, and therapeutic aspects of the most common IMD of carbohydrates in >360 patients diagnosed at our institution.
Results: Clinical manifestations in children with IMD of carbohydrates are heterogeneous and may overlap with several diseases. The first symptoms of IMD of
galactose and fructose begin with acute manifestations of liver failure with impaired renal tubular functions and Fanconi syndrome. Most liver glycogenoses (GSD) begin with hepatomegaly, growth failure, attacks of hypoglycaemia after 2.5-3 hours of fasting, hepatopathy, dyslipidaemia and lactic
Keywords: inherited disorders of carbohydrate metabolism, galactosemia, hereditary fructose intolerance, glycogenoses, mucopolysaccharidoses, congenital disorders of glycosylation
Accepted: June 22, 2023; Prepublished online: June 22, 2023; Published: June 23, 2023 Show citation
References
- Ferreira CR, Rahman S, Keller M, et al. An international classification of inherited metabolic disorders (ICIMD). J Inherit Metab Dis 2021; 44(1): 164-177.
Go to original source...
Go to PubMed...
- Honzík T, Kožich V, Pešková K, et al. Laboratorní novorozenecký screening. Ces-slov Pediat 2022; 77(1): 12-18.
Go to original source...
- Welling L, Bernstein LE, Berry GT, et al. International clinical guideline for the management of classical galactosemia: diagnosis, treatment, and follow-up. J Inherit Metab Dis 2017; 40(2): 171-176.
Go to original source...
Go to PubMed...
- Honzík T, Zeman J. Výživa u dědičných metabolických poruch. In: Kohout P, et al. Klinická výživa. Praha: Galén 2021: 779-798.
- Steinmann B, Santer R. Disorders of fructose metabolism. In: Saudubray JM, Baumgartner MR, García-Cazorla A, et al. Inborn metabolic diseases: diagnosis and treatment. 7th ed. Heidelberg: Springer 2022: 327-336.
Go to original source...
- Honzík T, Zeman J, et al. Dědičné poruchy metabolismu v kazuistikách. Praha: Mladá fronta, 2016.
- Walter JH, Labrune P, Laforet P. The glycogen storage diseases and related disorders. In: Saudubray JM, Baumgartner MR, García-Cazorla A, et al. Inborn metabolic diseases: diagnosis and treatment. 7th ed. Heidelberg: Springer 2022: 179-200.
Go to original source...
- Grünert SC, Elling R, Maag B, et al. Improved inflammatory bowel disease, wound healing and normal oxidative burst under treatment with empagliflozin in glycogen storage disease type Ib. Orphanet J Rare Dis 2020; 15(1): 218.
Go to original source...
Go to PubMed...
- Rossi A, Hoogeveen IJ, Bastek VB, et al. Dietary lipids in glycogen storage disease type III: A systemic literature study, case studies, and future recommendations. J Inherit Metab Dis 2020; 43(4): 770-777.
Go to original source...
Go to PubMed...
- Kolářová H, Ješina P. Metabolické myopatie. Neurologie pro praxi 2022; 23(1): 24-32.
Go to original source...
- Semplicini C, De Antonio M, Taouagh N, et al. Long-term benefit of enzyme replacement therapy with alglucosidase alfa in adults with Pompe disease: prospective analysis from the French Pompe Registry. J Inherit Metab Dis 2020; 43(6): 1219-1231.
Go to original source...
Go to PubMed...
- Santer R, Klepper J. Disorders of glucose and monocarboxylate transporters. In: Saudubray JM, Baumgartner MR, García-Cazorla A, et al. Inborn metabolic diseases: diagnosis and treatment. 7th ed. Heidelberg: Springer, 2022: 228-230.
Go to original source...
- Jones S, Wijburg FA. Glykosaminoglycans and oligosaccharides disorders: glycosaminoglycans synthesis defects, mucopolosaccharidoses, oligosaccharidoses and sialic acid disorderes. In: Saudubray JM, Baumgartner MR, García-Cazorla A, et al. Inborn metabolic diseases: diagnosis and treatment. 7th ed. Heidelberg: Springer, 2022: 766-777.
Go to original source...
- Murgasova L, Jurovcik M, Jesina P, et al. Otorhinolaryngological manifestations in 61 patients with mucopolysaccharidosis. In J Pediatr Otorhinolaryngol 2020; 135: 110137.
Go to original source...
- Formánková R, Říha P, Keslová P, et al. Transplantace kmenových buněk krvetvorby u dětí s dědičnými metabolickými poruchami a maligní infantilní osteopetrózou. Ces-slov Pediat 2022; 77(5): 276-283.
Go to original source...
- Dvorakova L, Vlaskova H, Sarajlija A, et al. Genotype-phenotype correlation in 44 Czech, Slovak, Croatian and Serbian patients with mucopolysaccharidosis type II. Clin Genet 2017; 91(5): 787-796.
Go to original source...
Go to PubMed...
- Jaeken J, Morava E. Congenital disorders of glycosylation, dolichol and glycosylphosphatidylinositol metabolism. In: Saudubray JM, Baumgartner MR, García-Cazorla A, et al. Inborn metabolic diseases: diagnosis and treatment. 7th ed. Heidelberg: Springer, 2022: 811-832.
Go to original source...
- Ondruskova N, Cechova A, Hansikova H. Congenital disorders of glycosylation: Still "hot" in 2020. Biochim Biophys Acta Gen Subj 2021; 1865(1): 129751.
Go to original source...
Go to PubMed...
- Altassan R, Péanne R, Jaeken J, et al. International guidelines for the management of phosphomannomutase 2-congenital disorders of glycosylation: diagnosis, treatment and follow up. J Inherit Metab Dis 2019; 42(1): 5-28.
Go to original source...
Go to PubMed...
- Čechová A, Ondrušková N, Tesařová M, et al. Deficit fosfomanomutázy 2: klinická, biochemická a molekulárně-genetická charakteristika 22 pacientů diagnostikovaných v České republice. Ces-slov Pediat 2018; 73(6): 365-374.
- Čechová A, Altassan R, Borgel D, et al. Consensus guidelines for the diagnosis and management of mannose phosphate isomerase-congenital disorder of glycosylation. J Inherit Metab Dis 2020; 43(4): 671-693.
Go to original source...
Go to PubMed...
- Altassan R, Radenkovic S, Edmondson AC, et al. International consensus guidelines for phosphoglucomutase 1 deficiency (PGM1-CDG): diagnosis, follow up, and management. J Inherit Metab Dis 2021; 44(1): 148-163.
Go to original source...
Go to PubMed...
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.